The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various socioeconomic and clinical factors.

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

Urine VOCs are linked to COPD risk and inflammation in NHANES data, suggesting potential for non-invasive screening with strong diagnostic accuracy.

Modern medicine is largely reactive—treating illness only after symptoms emerge. But a new study from the Research Institute ...

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

Astegolimab met its primary endpoint in the Phase IIb ALIENTO trial with a 15.4% reduction in annualized exacerbation rate at 52 weeks, while the Phase III ARNASA study showed a 14.5% reduction and ...

Roche’s IgG2 monoclonal antibody (mAb) astegolimab has yielded mixed results in chronic obstructive pulmonary disease (COPD), succeeding in a Phase IIb trial but failing in a Phase III study.

UBC Okanagan researchers have developed a 3D bio-printed model that closely mimics the complexity of natural lung tissue, an innovation that could transform how scientists study lung disease and ...

Your sleep tracker might be more honest than you are. A massive study reveals poor sleep rhythm—not sleep duration—is what ...

A study suggests that a single brain MRI can be used to predict a person's rate of aging across their whole body, which researchers say could change how we predict and prevent chronic disease.